Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting report
- 8 November 2023
- Vol. 41 (49) , 7307-7312
Abstract
No abstract availableKeywords
Funding Information
- World Health Organization
- European Commission
This publication has 53 references indexed in Scilit:
- Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus DiseaseThe Journal of Infectious Diseases, 2017
- Research and development of Zika virus vaccinesnpj Vaccines, 2016
- Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogenScience, 2015
- Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patientsNature Communications, 2014
- Efficacy Trial of a DNA/rAd5 HIV-1 Preventive VaccineNew England Journal of Medicine, 2013
- Efficacy Results of a Trial of a Herpes Simplex VaccineNew England Journal of Medicine, 2012
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandNew England Journal of Medicine, 2009
- Glycoprotein-D–Adjuvant Vaccine to Prevent Genital HerpesNew England Journal of Medicine, 2002
- Recombinant Glycoprotein Vaccine for the Prevention of Genital HSV-2 InfectionJAMA, 1999
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998